Citations

Showing 10 of 108152 citations.

2301 Hepatic Adenoma Misdiagnosed as Biliary Colic
Pitlick, Mitchell M. , Stephenson, Christopher R.

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S1285-S1285

10.14309/01.ajg.0000598736.03018.2c Get It

INTRODUCTION: We present the case of a woman who presented on multiple occasions with abdominal pain attributed to biliary colic that was eventually diagnosed as a hemorrhagic hepatic adenoma. We emphasize the importance of keeping a wide differential diagnosis for a common gastrointestinal complaint, the importance of medication review, and the benefit of patient-centered care. CASE DESCRIPTION/METHODS: A 37 year old female presented to the emergency department with right upper quadrant pain. She had pain for the past month that was more severe and constant in the past week. She had no fevers, chills, vomiting, or diarrhea. Her only medication was ethinyl estradiol for endometriosis. Her pain had been attributed to biliary colic at prior clinic appointments. She had right upper quadrant tenderness without peritoneal signs. A complete blood count and complete metabolic panel were unremarkable. A CT scan showed a 4.9 × 3.9 × 3.9 cm hepatic mass, with subsequent MRI demonstrating intrinsic T1 hyperintense signal consistent with a hepatic adenoma with recent hemorrhage. The patient declined to stop her estrogen without further endometriosis therapy, so she underwent simultaneous laparoscopic liver wedge resection and robotic hysterectomy with bilateral salpingo-oopherectomy. She now has some minor residual pain but is doing well. DISCUSSION: Hepatic adenomas are uncommon liver tumors classically associated with oral contraceptive (OCP) use. The annual incidence is 1 in 1,000,000 in non OCP users, but increases to 30-40 per 1,000,000 in those with long term OCP use. The risk increases with both increasing dose and duration of therapy. OCPs not only increase the incidence of hepatic adenomas, but they tend to be larger, more numerous, and more likely to bleed in patients who take OCPs. In this case, premature closure by multiple providers led to anchoring on the diagnosis of biliary colic. The association between her use of ethinyl estradiol and the possibility of hepatic adenoma was not recognized until her adenoma had begun to bleed, which could have resulted in a catastrophic outcome. This highlights the need to keep a broad differential and perform an adequate medication review for patients that present with this common gastrointestinal complaint. Additionally, prioritizing the patient’s preference to control her endometriosis pain led to consultation with the appropriate surgical teams that ultimately led to a positive outcome for the patient.
2162 Cryotherapy for Management of Transfusion-Dependent Gastrointestinal Hemorrhage Secondary to Gastric Antral Vascular Ectasia
Hanada, Yuri , Wang, Kenneth K.

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S1207-S1207

10.14309/01.ajg.0000598180.51180.80 Get It

INTRODUCTION: Non-variceal upper gastrointestinal hemorrhage is traditionally managed with mechanical devices, thermal coagulation, or injection therapy. However, due to specific lesion characteristics, certain cases may not be easily or effectively managed by these methods, in which case either a novel therapy or repurposing of an existing technique could be considered. Here, we present a case of gastric antral vascular ectasia (GAVE) addressed with cryotherapy. CASE DESCRIPTION/METHODS: An 82 year old man with CAD s/p CABG, AS s/p AVR, symptomatic AVB s/p PPM, HTN, and BPH presented to his primary care provider Clinic with chronic, symptomatic, transfusion-dependent iron-deficiency anemia with a hemoglobin nadir of 6.7 g/dL from 12.2 g/dL four months prior. The patient also reported possible melena, though stool appearance was obscured by oral iron supplementation. He underwent diagnostic EGD, which identified severe GAVE with mild associated bleeding throughout the entire stomach. This was therapeutically managed with APC, but given the severity and diffuse nature of the GAVE (Figure 1), the patient was referred for cryotherapy. Medically, the patient was recommended to initiate PPI therapy and continue iron supplementation. Three sessions occurring at 1 month intervals were completed, followed by one session 3 months out. By the third session, the patient no longer required transfusional support to maintain appropriate hemoglobin levels. On endoscopic follow-up 6 months out (one year from initial EGD), the GAVE had improved in severity (Figure 2). DISCUSSION: The current treatment of GAVE primarily involves argon plasma coagulation, which is limited by its inability to treat large areas of mucosa in an efficient manner. However, data supporting the use of cryotherapy as a safe and effective treatment for GAVE are emerging. Patients with diffuse, extensive mucosal gastrointestinal lesions should be referred to a tertiary care center to assess cryotherapy candidacy.
2119 Acute Post-Operative Drainage With a Lumen-Apposing Metal Stent (LAMS)
McDonald, Nicholas , Storm, Andrew C.

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S1180-S1181

10.14309/01.ajg.0000598008.45342.50 Get It

INTRODUCTION: Peripancreatic fluid collections may occur following pancreatic resection and are traditionally managed by percutaneous surgical drains. Endoscopic management of these peripancreatic fluid collections is increasingly utilized and there is growing experience in this realm. CASE DESCRIPTION/METHODS: A 54-year-old woman with a history of resectable adenocarcinoma of the pancreatic tail (T1a) who received FOLFIRINOX neoadjuvant therapy and was transitioned to Gemcitabine/Abraxane, presented for surgical management. She initially underwent laparoscopic, hand-assisted distal pancreatectomy and splenectomy. She tolerated surgery with no immediate complications. On postoperative day #4, she developed moderate abdominal pain. Computed tomography (CT) demonstrated an irregularly-shaped, hypodense fluid collection measuring 7.5 × 6.5 × 8.3 cm about the pancreatic tail, concerning for pancreatic duct leak. The decision was made to perform endoscopic drainage under endoscopic ultrasound guidance. On postoperative day 6, EUS demonstrated a 7 × 4 cm septated collection in the postoperative bed in the region of the distal pancreas (Figure A). The acute collection had not yet become walled off based on CT and EUS. The common wall between the stomach and cyst was interrogated utilizing color Doppler and an ideal puncture sight was determined. An electrocautery enhanced lumen apposing metal stent (LAMS) was advanced into the cyst and a 10 × 10 mm LAMS was placed with flanges in close approximation to the fluid collection and stomach wall through cystgastrostomy (Figure B). An additional 7 Fr by 4 cm soft double pigtail stent was then placed coaxial to the LAMS to maintain patency. At follow-up, two weeks later, her abdominal symptoms had resolved. Her interval scan demonstrated a significantly decreased pancreatic tail collection and transgastric LAMS. At postoperative day 10, cross sectional imaging demonstrated complete resolution of her fluid collection, and endoscopy was performed with uneventful LAMS removal (Figure C). DISCUSSION: This case demonstrates a patient with an acute postoperative peripancreatic fluid collection after distal pancreatectomy which was successfully treated six days postoperatively with transgastric cystgastrostomy using a LAMS. While traditional management in the acute postoperative setting has been percutaneous drain placement, further study is needed to evaluate the safety and efficacy of minimally invasive, endoscopic methods of postoperative drainage.
2110 A Case of IgA Vasculitis in Crohn’s Disease and Recurrent Clostridioides difficile Infection
Voth, Elida , Olson, Emily, Raffals, Laura E. , Olson, Emily

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S1175-S1175

10.14309/01.ajg.0000597972.33667.cd Get It

INTRODUCTION: IgA vasculitis (IgAV) is an immune-mediated systemic vasculitis characterized by palpable purpura, arthralgias, abdominal pain, and renal disease. Approximately 90% of cases occur in children; however, adults are at increased risk for more severe disease. The pathogenesis of IgAV is associated with inflammatory, infectious, autoimmune, and medication triggers, including tumor necrosis factor (TNF) alpha inhibitors. We describe a case of a man with Crohn’s disease (CD) who developed IgAV in the setting of a perirectal abscess, recurrent Clostridioides difficile infection (CDI), and anti-TNF therapy. CASE DESCRIPTION/METHODS: A 20 year old man with ileocolonic Crohn’s disease and perianal involvement, inflammatory arthropathy, and recurrent CDI presented to an outside ED with increased abdominal pain and rash on the extremities, trunk, and soft palate. Medications included etanercept, vedolizumab, and prednisolone. In the ED, the patient was hypotensive and tachycardic. CT abdomen/pelvis noted multifocal active inflammatory disease and a 3.2 cm abscess in the left ischiorectal fossa. He was initiated on broad spectrum antibiotics for septic shock and underwent emergent perirectal drain placement; post-operatively, his shock resolved. He was transferred to our institution for further management. Upon arrival, the patient was hemodynamically stable and remained on broad spectrum antibiotics and high dose prednisolone. Review of systems was notable for worsening abdominal pain and hematuria. Biopsy of the rash demonstrated IgA vasculitis. C. difficile toxin PCR was positive. Repeat urinalysis demonstrated nephrotic range proteinuria and hematuria, consistent with IgA nephropathy. ACE-inhibitor therapy was initiated, and skin lesions gradually improved with topical triamcinolone. DISCUSSION: We report a case of a patient with ileocolonic and perianal Crohn’s disease on TNF-alpha inhibitor therapy who developed IgA vasculitis in the setting of septic shock secondary to perirectal abscess and recurrent CDI. This case highlights anti-TNF therapy, infection and inflammatory bowel diseases as potential causes of systemic vasculitis. A high clinical suspicion is needed in order to obtain an early histopathologic diagnosis for IgAV and prompt evaluation of other organ system involvement.
1838 Esophageal Leukoplakia
Hernandez, Patricia V. , Snyder, Diana L. , Wang, Kenneth K. , Katzka, David A. , Horsley‐Silva, Jennifer L. , Kahn, Allon

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S1032-S1032

10.14309/01.ajg.0000596884.51387.d5 Get It

INTRODUCTION: Epidermal metaplasia is a histological correlate to a white patch on the surface of a mucous membrane that cannot be rubbed off, known as leukoplakia. It is a common finding in oral mucosa, however rare in esophageal mucosa. Etiology of this condition in the esophagus is unclear, thought to be associated with esophageal tobacco and alcohol exposure or possibly an unusual response to chronic acid reflux. In contrast to oral leukoplakia there is a female predominance. Although generally asymptomatic, symptom presentation can include dysphagia. Endoscopic features include slightly elevated whitish surface, which can be translucent or cobblestone-like in appearance. The natural history is unknown though there is concern for an increased risk of squamous cell cancer. Due to paucity of published studies about this condition, we aim to report a case treated with endoscopic submucosal dissection (ESD). CASE DESCRIPTION/METHODS: A 64-year-old Caucasian man with a history of tobacco use and stable weight, presented to Gastroenterology clinic due to an 11-month history of solid food esophageal dysphagia. Physical examination was unremarkable. Upper endoscopy demonstrated white plaques at the gastroesophageal junction (Figure 1A and B). Biopsies obtained from this abnormality showed esophageal epidermoid metaplasia consistent with leukoplakia and mild patchy active chronic inflammation. GMS stain for fungal organisms was negative. An ESD procedure was planned, due to lesion size to ensure complete removal. Chromoscopy with methylene blue was used to mark the borders of the lesion and ESD was accomplished without adverse events (Figure 1C). Histologic examination confirmed hyperplastic squamous esophageal mucosa with marked hyperkeratosis without dysplasia and negative margins. During 2 year follow up, patient reported complete resolution of his dysphagia. DISCUSSION: The management strategy for esophageal leukoplakia is not well defined though reports suggest that endoscopic resection and surveillance are warranted. Here we represent a case where symptoms resolved and the lesion was completely removed by ESD.
1820 Dysphagia Lusoria: When Surgery Is the Bitter Pill to Swallow
Werlang, Monia E., Paniz, Graziella Rangel , Brahmbhatt, Bhaumik

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S1021-S1022

10.14309/01.ajg.0000596812.65741.73 Get It

INTRODUCTION: Aberrant subclavian artery (ASA) is a rare anatomic variant and frequently asymptomaticcondition. We present a case of a young patient with progressive dysphagia who underwent extensive workup and repetitive endoscopic procedures until diagnosed. CASE DESCRIPTION/METHODS: 35-year-old female with history of systemic lupus erythematous, presented with progressive dysphagia for several weeks. No preceding trauma, procedures or infections. She had anunremarkable upper endoscopy, but an empiric esophageal dilation was performed. However, in few months her symptoms recurred; another dilation was pursued along with proton pump inhibitor therapy and dietary changes. Three years later, she had worsening dysphagia, leading to an 8-pound weight loss. An esophagram raised suspicion for an extrinsic esophageal compression (Figure 1). A computed tomography (CT) angiogram confirmed the presence of a right ASA (Figure 2). Patient was referred to thoracic surgery and underwent operative repair of right ASA (Figure 3). A repeated esophagram on the 5th day after surgery, showing no delay in the passage of the barium pill. Upon discharge, she was tolerating soft diet and in one month she was able to eat normally. DISCUSSION: ASA is characterized by a vascular ring structure due to aberrant arising of one of the subclavian arteries (arteria lusoria) from the aortic arch. Although ASA is the most common congenital aortic arch anomaly, it occurs in less than 2.5% of overall population. Its management depends on symptoms: if mild and intermittent, dietary and behavioral modifications are appropriate; if severe dysphagia, surgery should be considered. During adulthood, 30% of patients are symptomatic with intermittent dysphagia being the most prominent symptom. Late presentation is probably related with atherosclerosis and aneurismal formation due to advancing age. Even though ASA is found mostly in women and its possible relation with atherosclerosis, we could not find any data in literature linking ASA to SLE. Dysphagia lusoria can be easily diagnosed by barium esophagogram, an inexpensive test which would typically show an impression defect at the level of the third or fourth vertebra. Esophageal manometry and upper endoscopy usually are unrevealing but a CT angiogram can confirm the diagnosis. Because of its rarity, ASA is not commonly suspected upon evaluation of dysphagia in adults, often times causing recurrent endoscopies and other non-revealing tests to be repeated.
1654 An Unusual Colon Lesion: Colon Metastasis From Primary Lung Adenocarcinoma
Meade, Charles , Hansel, Stephanie L.

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S923-S924

10.14309/01.ajg.0000596144.06597.68 Get It

INTRODUCTION: Primary lung cancers infrequently metastasize to the gastrointestinal tract. We describe one case of isolated colonic metastasis identified at diagnosis of the primary lung malignancy and the associated immunohistochemical pattern. CASE DESCRIPTION/METHODS: An 80-year-old man presented for evaluation of subacute onset shortness of breath. CT imaging showed a spiculated mass with associated ipsilateral intrathoracic lymphadenopathy. PET-CT was performed for staging and revealed a hypermetabolic focus in the left colon with recommendation for follow up colonoscopy. No other significant lesions or evidence of distant metastatic disease were seen and subsequent biopsy of a subcarinal lymph node demonstrated primary pulmonary adenocarcinoma. The colonoscopy visualized a sessile 12 mm polyp in the recto-sigmoid colon (Figure 1). Prior colonoscopy within 5 years of presentation was normal. Colon polyp morphology showed moderately differentiated adenocarcinoma. Immunohistochemical staining of resected polyp was positive for TTF-1 and negative for CDX2. Oncology recommended tyrosine kinase inhibitor therapy for Stage IV disease and alectinib was initiated with good response at 6 month follow up. DISCUSSION: Non-small cell lung cancer metastatic to the colon is uncommon but can present as a spectrum from asymptomatic mucosal involvement to bulky obstructive disease. Autopsy series and published case reports suggest broad estimates of asymptomatic involvement in between 1-10% of lung primaries, with symptomatic gastrointestinal involvement in <1% of cases. 1 Endoscopic presentation of metastatic disease to the gastrointestinal tract is often non-characteristic and differentiating adenocarcinoma tissue of origin is aided by immunohistochemical staining. TTF-1 staining has been shown to be highly specific to pulmonary adenocarcinomas. 2 CDX2 expression is an important intestine-specific transcription factor, and CDX2 negativity suggests adenocarcinoma of non-GI origin. 3 Used in conjunction, distant metastatic disease to the GI tract can be identified.
1536 An Uncommon Case of Small Bowel and Pan-Colonic Varices
DiCarlo, Vick S., Ravi, Sujan, Kamath, Patrick S. , Shoreibah, Mohamed

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S850-S852

10.14309/01.ajg.0000595672.17861.3b Get It

INTRODUCTION: We present a case of idiopathic varices in the small bowel and colon discovered after extensive work up for iron-deficiency anemia and portal hypertension. CASE DESCRIPTION/METHODS: 41-year-old with no known medical history underwent esophagogastroduodenoscopy (EGD) and colonoscopy for evaluation of iron-deficiency anemia. EGD was normal. Colonoscopy revealed diffuse colonic varices extending from the cecum to the rectum (Figure 1). Computed tomography enterography showed numerous varices of the mid jejunum. Magnetic resonance imaging of the abdomen showed patent portal circulation and no other abnormalities. Echocardiogram did not show any evidence of right heart failure. Transjugular liver biopsy showed a portosytemic pressure gradient of 4 mm of Hg indicating the absence of portal hypertension. Liver biopsy only showed mild steatosis and no fibrosis. A direct measurement of portal pressure was 3 mmof Hg again indicating the absence of portal hypertension. DISCUSSION: Given the extensive workup with no evidence of portal hypertension, patient is thought have idiopathic varices in the small bowel and colon. Ectopic varices, especially in the colon are rare and are usually associated with portal hypertension. Idiopathic colonic varices in association with small bowel varices are even more infrequently described in existing literature. Clinical presentation has been reported with massive hemorrhage, recurrent bleeds and even as incidental findings in endoscopies and imaging performed for other reasons. Management options include conservative frequent follow up or surgery if there is evidence of recurrent bleeds or massive hemorrhage.
1345 Pancreatic Pseudocyst Leading to Gastric Outlet Obstruction: A Hard Diagnosis to Swallow
Falde, Sam, Kamboj, Amrit K. , Dines, Virginia

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S744-S745

10.14309/01.ajg.0000594908.70639.1d Get It

INTRODUCTION: Recurrent pancreatitis with pseudocyst can present with gastric outlet obstruction. Endoscopic evaluation should be utilized in certain contexts, especially to exclude more sinister causes of this presentation. CASE DESCRIPTION/METHODS: A 43-year-old woman with a history of alcohol use disorder presented with a gastric outlet obstruction. This was felt secondary to a pancreatic pseudocyst given multiple episodes of recurrent pancreatitis, the last being 1 week prior to her current admission. On presentation, physical exam was significant for ascites and epigastric tenderness. Labs were notable for AST 214 U/L, ALT 99 U/L, alkaline phosphatase 147 U/L, lipase of 203 U/L, and negatives serum alcohol. Notably, Ca 19-9 was elevated to 154 IU/mL during admission 2 weeks prior. Computed tomography chest and abdomen revealed bilateral pleural effusions, pseudocyst, and abdominal ascites. A thoracentesis and paracentesis were performed with cytology for both peritoneal fluid and pleural fluid confirming metastatic adenocarcinoma. Given her refractory symptoms, an esophagogastroduodenoscopy (EGD) was performed which showed an obstructing tumor at the gastric outlet with biopsies revealing poorly differentiated gastric adenocarcinoma. A gastric stent was placed; however, she had continued nausea and vomiting. Repeat EGD showed gastric stent failure and subsequent endoscopic gastrojejunostomy with Axios stent was placed. The patient's functional status declined rapidly as a result of her advanced malignancy and on hospital day 8 she suffered a cardiac arrest, passing shortly after being transitioned to comfort cares. DISCUSSION: The patient's prior history of alcohol use disorder, recurrent pancreatitis, and imaging consistent with pancreatic pseudocyst made this case prone to numerous cognitive errors initially obscuring the etiology of her gastric outlet obstruction and pancreatitis. By reframing the presentation, we were able to question pancreatic pseudocyst as the sole source of the gastric outlet obstruction. Traditionally, Ca 19-9 is associated with pancreatic adenocarcinoma. It also can be elevated in the setting of other gastric malignancies and acute pancreatitis. In pancreatitis, absolute value and trends of Ca 19-9 can help differentiate between pancreatitis and malignancy. The diagnostic uncertainty around this patient's presentation with recurrent pancreatitis, pseudocyst, and gastric outlet obstruction required endoscopic evaluation to ultimately diagnose metastatic gastric adenocarcinoma.
1247 Development of a Patient Reported Outcome (PRO) Questionnaire to Assess the Symptoms of Eosinophilic Gastritis and Gastroenteritis (EG/EGE-SQ©)
Hirano, Ikuo , Banderas, Benjamin , Woolley, J. Michael, Ollis, Sarah , Love, Emily, Shields, Alan L. , Shaw, Camilla, Rasmussen, Henrik , Dellon, Evan S. , Murray, Joseph A. , Peterson, Kathryn A. , Foley, Catherine

Mayo Clinic

American Journal of Gastroenterology | October 8, 2019 | Volume: 114 | Issue: 1 | Pages: S694-S695

10.14309/01.ajg.0000594516.37251.84 Get It

INTRODUCTION: Patients with eosinophilic gastritis and/or gastroenteritis (EG/EGE) experience significantly reduced health-related quality of life related to the symptoms and signs of their disease. There is a need to develop a PRO questionnaire for clinical research in EG/EGE. The objectives of this study were to develop a symptom questionnaire (drafted using literature and clinician input to determine preliminary measurement concepts) and then (1) identify, describe, and substantiate signs, symptoms, and impacts of EG/EGE from the perspective of adults with the condition via concept elicitation methods; and (2) evaluate the properties of the questionnaire and make modifications via cognitive debriefing methods. METHODS: Interviews were conducted, transcribed, coded, and analyzed. Eligible adults with EG/EGE first participated in a concept elicitation segment where they described their experiences with EG/EGE, continuing until saturation was achieved, adding symptoms to the draft symptom questionnaire as needed. This was followed by a cognitive debrief to assess the appropriateness of the draft symptom questionnaire, where patients assessed readability, comprehensibility, relevance, and comprehensiveness. The questionnaire was modified based on patient feedback, then re-evaluated to confirm its appropriateness. RESULTS: In total, 16 interviews were conducted and 24 signs and symptoms were reported during concept elicitation. The most frequently reported (Figure 1) were abdominal pain, nausea, diarrhea, vomiting, and abdominal cramping; while abdominal pain, nausea, and diarrhea were the most bothersome to patients. Saturation was achieved after 12 interviews. In the cognitive debriefing, revisions included the addition of a vomiting frequency item and revision of the early satiety item for clarity. Response options were modified to instruct the participants to assess each symptom “at its worst”. For the final version of the EG/EGE-SQ©, participants were able to read, comprehend, and provide appropriate responses, and reported that the resulting questionnaire was comprehensive for their condition. CONCLUSION: The results of this research support the content validity, including comprehensiveness and interpretability, of the EG/EGE-SQ© which offers the potential for use in clinical research to assess symptoms in patients with EG/EGE. Future research is needed to assess its psychometric properties including reliability and validity, responsiveness, and potential for use in pediatric populations.